New lead reported in tumor angiogenesis
Scientists supported by the National Institute of Dental and Craniofacial Research (NIDCR), part of the National Institutes of Health, have added a key new piece to the puzzle of how tumor cells induce new blood vessels to form and fuel their abnormal growth, a well-known process called angiogenesis. As published in this month's issue of the journal Cancer Cell, the scientists found that i...Growth factor-promoting angiogenesis expressed in tumor cells and normal neurons
Scientists have discovered that a stem cell factor overexpressed both in brain tumor cells and in neurons following brain injury promotes tumor survival by inducing angiogenesis. The research study, published in the April issue of Cancer Cell, examines the interaction between tumor cells and surrounding tissues and may have substantial significance for design of more effective therapeutics for on...Schepens scientists are first to discover angiogenesis switch inside blood vessel cells
Scientists at Schepens Eye Research Institute, an affiliate of Harvard Medical School, are the first to discover a switch inside blood vessel cells that controls angiogenesis (new blood vessel growth). The switch, they learned, is turned on and off by the balance between two enzymes (known as PI3K and PLCg) that compete for the use of the same lipid membrane to fulfill opposite missions, growth a...New angiogenesis finding may help fight cancer growth
A researcher at the University of Wisconsin-Madison School of Medicine and Public Health has discovered a new part of the complicated mechanism that governs the formation of blood vessels, or angiogenesis. The finding may help halt tumor growth in cancer patients, says Emery Bresnick, the senior author on the study, a professor of pharmacology and member of the UW-Madison Paul P. Carbone...Intrinsic eye protein halts angiogenesis
Dr. Jayakrishna Ambati, of the University of Kentucky, and Dr. Balamurali Ambati, of the Medical College of Georgia, have jointly published a paper in the journal Nature detailing major research discoveries in corneal avascularity and angiogenesis. In their paper published online Oct. 18, 2006, the researchers present evidence that unravels the mystery of how a healthy cornea remains clea...ChemiArray Mouse Lysate Angiogenesis Antibody Array I , 25 cytokines per membrane from CHEMICON
Description:Chemicons protein array systems, known as ChemiArrayTM Mouse Cytokine Antibody Arrays, are particularly useful compared with current methodologies. Besides the ability to detect protein expression, Chemicons systems present a more accurate reflection of active cytokine levels because they only detect secreted cytokines, and no amplification step is needed. Furthermore, it is simpler, faster, envi...Human Angiogenesis Antibody Array 2.1 (8) Kit, RayBio from Raybiotech, Inc.
Description:RayBio Human Angiogenesis Antibody Array 2.1 (8 array membranes) with Accessory, detects 23 angiogenic factors (for lysate) Antibody Array...Human Angiogenesis Array 1 Kit, Quantibody from Raybiotech, Inc.
Description:Quantibody Human Angiogenesis Array 1 (1 slide) Antibody Array...RayBio Mouse AngiogenesisAntibody Array I & 1.1 Service from Raybiotech, Inc.
Description:Request Info...Angiogenesis Tube formation Assay Kit from Upstate
Description:...An Image-Based Assay of Endothelial Cell Tube Formation as a Model of Angiogenesis
Formation of new blood vessels is fundamental to the development of cancerous cell masses and has therefore been the focus of many drug screening and cell signaling research studies. Blood vessel development is a significant event in the development and growth of solid tumors, and is implicated in wound h...Artificially made protein to inhibit angiogenesis
Researchers of Medical College of Georgia had successfully made a protein// that will stop the process of angiogenesis. Angiogenesis is the abnormal growth of blood vessels that may lead to obstructed vision or growth of a tumor. The new protein, when applied to animals suffering from corneal injury or skin cancer called melanoma, reduced the blood vessel proliferation by...Role Of MicroRNAs In Angiogenesis Researched
According to recent research, MicroRNAs are fine targets for future therapies.Researchers belonging to the University of Pennsylvania School of Veterinary //Medicine have demonstrated how microRNA molecules are responsible for the growth of blood vessels in a human colon cancer model. This process, known as angiogenesis, is a result of the ravenous cancer cells using blood vessels to gorge on a...New Angiogenesis Finding May Help Fight Cancer Growth
A researcher at the University of Wisconsin-Madison School of Medicine and Public Health has discovered a new part of the complicated mechanism that governs// the formation of blood vessels, or angiogenesis. The finding may help halt tumor growth in cancer patients, says Emery Bresnick, the senior author on the study, a professor of pharmacology and member of the UW-Madison Paul P. Ca...A Combination Of Drugs Used For Anti-Angiogenesis And Apoptosis More Effective
Imantanib is a drug which prevents the growth of new blood vessels, thereby inhibiting the growth of tumour(anti-angiogenesis). //It has been discovered that using Imantanib (Glivec [1]) and a drug that induces cell death (apoptosis) works better. It was found that the combination was more effective in stopping the growth of Ewing's sarcoma in mice than when either drug was given separately....Anti-fungal Drug Block Angiogenesis
Angiogenesis is the process by which the cancer cells ensure that new blood vessels feed it with nutrition to keep them growing; it is now discovered// that this can be blocked by a drug commonly used to treat toenail fungus called itraconazole. New Research at Johns Hopkins have discovered that in mice itraconazole reduced blood vessel growth by 67 percent compared to placebo. "We w...Vical Licensee AnGes MG Announces Positive Results of Phase 3 Angiogenesis Trial in Japan
SAN DIEGO, June 18, 2007 /PRNewswire-FirstCall/ -- VicalIncorporated today announced that the company's licensee, AnGes MG,Inc. reported positive results following interim analysis of datafrom the first 41 subjects to complete a Phase 3 trial of anangiogenesis product candidate using Vical's DNA deliverytechnology. Based on the findings that the primary efficacyendpoint in the trial had...